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The rare donor program at the Hospital Sírio Libanês 
began in 1990, with the encouragement of Delores Mallory, 
John Moulds, and Marcela Contreras, because at that time no 
such strategy was available in Brazil. In addition, an important 
contribution of rare sera was supplied by the international 
Serum, Cells and Rare Fluids (SCARF) program. Although 
managed by local funds and having a modest capacity for 
screening rare donors, all inventory units are available for any 
transfusion service either from Brazil or overseas.
Since the inception of our rare donor program, 84,426 
donors have been screened by serologic methods for several 
antigens, rendering a total of 161 rare donors, according to 
different blood group systems (Table 1). Furthermore, since 
2012, we have found 36 new rare donors who currently actively 
contribute with regular donations whenever needed.
Table 1 depicts our results through December 2014. In 
addition to testing all 84,426 donor samples for the main Rh 
antigens (D, C, c, E, e), we also tested for the presence of Goa 
(RH30) in 20,344 donors to potentially find DIVa donors. 
A total of 186 rare units (26 from 2012–2014) were made 
available to 75 Brazilian patients, not only in our hospital, but 
in 13 additional hospitals or blood services facilities across the 
country. In addition, because storage of rare units in the frozen 
state is not widely available in Brazil, Hospital Sírio Libanês 
served as a facilitator for storage, thawing, and shipping of 34 
rare units that included k– (N = 1), K0 (N = 2), Kp(b–) (N = 
7), Yt(a–) (N = 10), Vel– (N = 12), and Di(b–) (N = 2), which 
were supplied either by national or international agencies 
(American Red Cross, New York Blood Center, Canadian Red 
Cross, and Osaka Red Cross) to seven blood services in the 
country during this period. There were two requests not filled 
during this period (one for a U– patient and one for an Rhnull 
patient).
We have not yet identified any Rhnull donors; this phenotype 
is recognized as the rarest in the world. Nevertheless, we 
understand that identifying such a donor, where high rates of 
failure are expected, can only be accomplished by an ongoing 
Rh antigen screening of all new donors, which we carry out in 
our service.
We were aware of one incompatible transfusion case: the 
serum from a previously transfused patient was sent to our 
laboratory for investigation and anti-Dib was identified. This 
patient was subsequently transfused with two Di(b–) units 
through  our rare donor program with no further hemolysis.
We have very strong support from voluntary non-
remunerated donors in our service. We provide no special 
incentives for either rare donors already in the program or 
for those who are enrolling through screening procedures. 
In other words, although rare donors are quite unique, they 
receive the same care provided to any regular voluntary donor. 
So far, we have not perceived any untoward effect by applying 
this policy.
In summary, a rare donor program requires perseverance, 
patience, and long-term commitment, given that one cannot 
predict when rare blood will be needed. Being part of a global 
program under the aegis of several agencies (International 
Society of Blood Transfusion, AABB, American Red Cross, 
EFS [Etablissement Français du Sang], Canadian Red Cross, 
Japanese Red Cross, Sanquin, etc.) with active cooperation 
Table 1. Phenotypes of rare blood donors identified at the Hospital 
Sírio Libanês as of 2014
Phenotype Tested donors* Total 2012–2014†
k– 84,656 118 24
Di(b–) 40,551 13 4
r'r' 84,426 6 3
r''r'' 84,426 5 1
Kp(b–) 50,232 5 1
RzRz 84,426 3 1
ryry 84,426 2 0
Vel– 9,477 2 0
Kx– (McLeod) 50,232 2 0
Oh (Bombay) 84,426 2 1
K0 50,232 1 1
U– 17,163 1 0
PP1Pk– 23,050 1 0
Jk(a–b–) 32,915 0 0
Total 161 36
*Since 1990.
† New donors added to our rolls between January 2012 and December 2014.
14 IMMUNOHEMATOLOGY, Volume 32, Number 1, 2016
S. Wendel et al.
and mutual support increases the chances of finding a rare 
unit for a rare patient.
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